Mesenchymal Stem Cell Treatment for Steroid Refractory
Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey

<div>Two-year Kaplan-Meier estimate of overall survival according to response to mesenchymal stromal cell treatment. CR: complete response, PR/NR: partial or nonresponse, <svg height="6.20645pt" id="M14" style="vertical-align:-0.2063999pt" version="1.1" viewbox="-0.0498162 -6.00005 6.78059 6.20645" width="6.78059pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M504 89L488 119C453 85 428 69 416 69C408 69 405 75 412 102L462 304C492 438 460 451 436 451S388 441 356 423C311 397 229 336 170 256H168L189 340C208 418 200 451 177 451C144 451 82 413 24 352L40 322C65 345 98 369 108 369C114 369 119 363 112 335L28 -3L36 -12C54 -3 83 4 112 10C125 73 138 122 153 174C205 258 328 382 376 382C395 382 399 369 384 305L330 93C312 25 323 -12 351 -12C378 -12 439 21 504 89Z" id="g50-111"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="512" vert-adv-y="512"></glyph.data></g></svg>: number, and <svg height="8.64656pt" id="M15" style="vertical-align:-0.04981995pt" version="1.1" viewbox="-0.0498162 -8.59674 8.229 8.64656" width="8.229pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M615 650H141L132 618C223 612 227 607 212 526L136 123C122 42 112 38 27 32L18 0H522C539 33 580 135 592 166L558 179C536 139 512 100 486 75C454 48 420 41 345 41C287 41 252 42 237 55C221 68 220 100 231 158L261 316H357C455 316 455 309 455 235H489L529 437H494C468 366 460 360 369 360H269L305 565C315 609 316 611 357 611H450C525 611 535 599 548 578C559 556 561 526 560 482L595 486L615 650Z" id="g50-70"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="639" vert-adv-y="639"></glyph.data></g></svg>: event.</div>

Stem Cells International

fig1

Figure 1

Figure 1: Mesenchymal Stem Cell Treatment for Steroid Refractory
Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey 

Stem Cells International

Mesenchymal Stem Cell Treatment for Steroid Refractory Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey

Figure 1